Eryped
Gastroparesis, Erythrasma, Whooping Cough + 60 more
Treatment
68 FDA approvals
20 Active Studies for Eryped
Treatment for
Gastroparesis
What is Eryped
Erythromycin
The Generic name of this drug
Treatment Summary
Erythromycin is an antibiotic drug that stops the growth of certain bacteria. It was first discovered in 1952 and can be used to treat a variety of bacterial infections. Erythromycin is available in different forms, including IV, topical, and eye drops. It is part of the macrolide group of antibiotics, which includes azithromycin, clarithromycin, and spiramycin.
Erythrocin Stearate
is the brand name
Eryped Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erythrocin Stearate
Erythromycin
1964
261
Approved as Treatment by the FDA
Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 68 uses which include Corynebacterium Infections and Acne Vulgaris .
Corynebacterium Infections
Acne Vulgaris
Used to treat Acne Vulgaris in combination with Tretinoin
Acne Vulgaris
Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin
Urethritis
urogenital infections during pregnancy
Pertussis
treponema pallidum infection
Diphtheria
Bacterial Infections
Staphylococcus (S.) Aureus Infection
penicillins
Communicable Diseases
Conjunctivitis
Respiratory Tract Infections
Erythrasma
Postoperative Infections
Listeriosis
Corynebacterium minutissimum infection
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
Pneumonia, Mycoplasma
Whooping Cough
Bordetella Pertussis Infection
uncomplicated endocervical infection
Staphylococcal Skin Infections
Communicable Diseases
pustular lesions
Used to treat pustular lesions in combination with Avobenzone
Communicable Diseases
Bacterial Infections
Whooping Cough
Pneumonia
Listeria infection
Listeria monocytogenes infection
Acute Otitis Media caused by Haemophilus Influenzae
Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole
inflammatory papular lesions
Used to treat inflammatory papular lesions in combination with Avobenzone
Amebiasis
Common Cold
Rheumatic Fever
prophylaxis of Postoperative Infections
Communicable Diseases
prophylaxis of Rheumatic fever
Ureaplasma urethritis
penicillins
Upper Respiratory Tract Infection
Streptococcus Pneumoniae Infections
Streptococcus pyogenes
Staphylococcal Skin Infections
Urethritis
Urinary Tract Infection (UTI)
Legionella pneumophila
Primary Syphilis
Lower Respiratory Tract Infection (LRTI)
Intestinal amebiasis caused by entamoeba histolytica
Skin and skin structure infections
Corynebacterium Infections
diphtheria antitoxin
Bronchitis
Haemophilus Influenzae Infections
Used to treat Haemophilus Influenzae Infections in combination with null
Urethritis
Ureaplasma urealyticum
skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes
Whooping Cough
Chlamydia Trachomatis
patients with intolerance or contraindications to tetracycline use
Syphilis
First episode of rheumatic fever
Rheumatic Fever
Pneumococcal Infections
Sulfonamides
Effectiveness
How Eryped Affects Patients
Erythromycin is an antibiotic that stops bacterial growth by preventing proteins from being made. It can be used to treat a variety of bacterial infections, but it is important to test for antibiotic resistance before administering the drug. Some strains of Haemophilus influenzae can be treated with a combination of erythromycin and sulfonamides, but Staphylococci may become resistant to erythromycin during treatment. Those taking erythromycin may experience pseudomembranous colitis, which can range from mild to life-threatening, and may also cause liver dysfunction, jaund
How Eryped works in the body
Erythromycin is an antibiotic that works by stopping bacteria from making proteins. It does this by targeting the ribosomal proteins in the cells of susceptible bacteria. This binding prevents the bacteria from forming proteins that it needs to replicate and grow, resulting in its death or control. Macrolides like erythromycin have a strong ability to bind to bacteria, which explains why they are so effective in treating a wide range of bacterial infections.
When to interrupt dosage
The dosage of Eryped is contingent upon the diagnosed condition, including Chlamydia Trachomatis, penicillins and Syphilis. The measure of dosage is dependent upon the administration procedure (e.g. Granule, for suspension or Tablet, film coated - Oral) detailed in the following table.
Condition
Dosage
Administration
Rheumatic Fever
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Gastroparesis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Whooping Cough
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Listeriosis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Endophthalmitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Bacterial Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Ophthalmia neonatorum (gonococcal)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Conjunctivitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Communicable Diseases
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Urinary Tract Infection (UTI)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Streptococcus pyogenes
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
First episode of rheumatic fever
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Communicable Diseases
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Corynebacterium Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Granuloma Inguinale
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Urethritis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Syphilis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Capsule, delayed release, Tablet, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release pellets, Intravenous, Powder, for solution - Intravenous, Powder, for solution, Liquid, Liquid - Oral, Powder, Lotion, Lotion - Topical, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release, Capsule, Delayed Release - Oral, Ointment - Topical, Wafer, Wafer - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Powder, for suspension - Oral, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder - Oral, Capsule, Capsule - Oral, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Lotion; Swab - Topical, Lotion; Swab
Warnings
Eryped has nine recognized contraindications, so it should not be ingested when afflicted with any of the conditions presented in the table below.
Eryped Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Erythromycin may interact with Pulse Frequency
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Eryped.
Common Eryped Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be increased when it is combined with Erythromycin.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Erythromycin.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Erythromycin.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Erythromycin.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Erythromycin.
Eryped Toxicity & Overdose Risk
The toxic dose of erythromycin in rats is 9272 mg/kg. Signs of overdosing on erythromycin include diarrhea, nausea, stomach cramps, and vomiting. If an overdose occurs, the drug should be stopped right away and any unabsorbed drug should be quickly eliminated. Supporting treatments should be given. Erythromycin cannot be completely removed from the body through dialysis.
Eryped Novel Uses: Which Conditions Have a Clinical Trial Featuring Eryped?
53 active studies are currently being conducted to investigate the potential of Eryped in providing relief from Streptococcus pyogenes, Treponema pallidum infection and Rheumatic Fever.
Condition
Clinical Trials
Trial Phases
Acne Vulgaris
3 Actively Recruiting
Phase 1, Phase 2, Phase 4
Listeriosis
0 Actively Recruiting
Legionella pneumophila
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Ureaplasma urealyticum
0 Actively Recruiting
Acute Otitis Media caused by Haemophilus Influenzae
0 Actively Recruiting
Gastroparesis
16 Actively Recruiting
Phase 3, Not Applicable, Early Phase 1
Acne Vulgaris
0 Actively Recruiting
Pneumococcal Infections
0 Actively Recruiting
Corynebacterium minutissimum infection
0 Actively Recruiting
Acne Vulgaris
0 Actively Recruiting
Urinary Tract Infection (UTI)
8 Actively Recruiting
Phase 1, Phase 3, Phase 4, Not Applicable, Phase 2
Urethritis
0 Actively Recruiting
Listeria monocytogenes infection
0 Actively Recruiting
Chlamydia Trachomatis
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
penicillins
1 Actively Recruiting
Phase 3
Primary Syphilis
0 Actively Recruiting
treponema pallidum infection
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
Eryped Reviews: What are patients saying about Eryped?
1
Patient Review
2/4/2011
Eryped for Bacterial Stomach or Intestine Infection caused by Anthrax
Patient Q&A Section about eryped
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is erythromycin ethylsuccinate used to treat?
"Erythromycin is used to treat infections caused by bacteria. Additionally, it may be taken as a preventative measure to reduce the likelihood of developing certain bacterial infections. Erythromycin is in a class of antibiotics known as macrolides, which work by inhibiting the growth of bacteria."
Answered by AI
What bacteria is erythromycin used to treat?
"Erythromycin can be used to treat bacteria that causes infections of the skin and upper respiratory tract, including Streptococcus, Staphylococcus, Haemophilus, and Corynebacterium genera."
Answered by AI
How long is EryPed good for?
"After adding water to the powder, EryPed 200, EryPed 400, and EryPed Drops must be stored at 77°F (25°C) or below and used within 35 days; refrigeration is not required."
Answered by AI
What is EryPed used to treat?
"EryPed is a prescription medication used to treat Intestinal Amebiasis, Legionnaire Disease, Pertussis, Streptococcal Infections, Primary Syphilis, and Urethritis. EryPed may be used alone or combined with other medications. EryPed belongs to a class of drugs called Macrolides, which work by killing bacteria or preventing their growth."
Answered by AI